[미국특허]
Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/60
A23D-009/013
A23D-007/00
A23D-007/005
A23D-007/01
A23L-001/035
A23L-001/29
A23L-001/30
A23L-001/305
A61K-009/00
A61K-009/107
A61K-036/286
A61K-036/47
A61K-047/14
A23L-001/00
출원번호
US-0255828
(2010-03-11)
등록번호
US-9034389
(2015-05-19)
국제출원번호
PCT/US2010/000723
(2010-03-11)
§371/§102 date
20111101
(20111101)
국제공개번호
WO2010/104575
(2010-09-16)
발명자
/ 주소
Driscoll, David F.
출원인 / 주소
STABLE SOLUTIONS LLC
대리인 / 주소
Buchanan Ingersoll & Rooney PC
인용정보
피인용 횟수 :
1인용 특허 :
23
초록▼
An emulsion is provided including: an oil component and a water component, the oil component including: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the oil component; wherein the fish oil triglycerides include omega-3 fatty acids, expressed as triglycerides,
An emulsion is provided including: an oil component and a water component, the oil component including: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the oil component; wherein the fish oil triglycerides include omega-3 fatty acids, expressed as triglycerides, in an amount of at least 60%, based on the total weight of the fatty acids of the fish oil triglycerides; wherein the fish oil triglycerides include a total amount of EPA and DHA, expressed as triglycerides, of at least 45%, based on the total weight of the fatty acids of the fish oil triglycerides; and, at least one medium-chain triglyceride, wherein a total amount of the at least one medium-chain triglyceride is from about 10% to about 40% based on the weight of the oil component.
대표청구항▼
1. An oil-in-water emulsion comprising: a) fish oil triglycerides consisting of glycerol which is esterified with fatty acids wherein said fatty acids comprise EPA and DHA in an amount of at least 45% by weight of said fatty acids and the total amount of omega-3 fatty acids is at least 60% by weight
1. An oil-in-water emulsion comprising: a) fish oil triglycerides consisting of glycerol which is esterified with fatty acids wherein said fatty acids comprise EPA and DHA in an amount of at least 45% by weight of said fatty acids and the total amount of omega-3 fatty acids is at least 60% by weight of said fatty acids, andb) at least one medium chain triglyceride oil, andwherein the fish oil triglycerides are present in an amount of at least 51% by weight based on the total weight of the oil component, and the medium chain triglycerides are present in an amount of 10% to 49% by weight based on the total weight of the oil component. 2. The oil-in-water emulsion of claim 1 wherein the fish oil triglycerides are present in an amount ranging from 51% to 90% by weight based on the total weight of the oil component. 3. The oil-in-water emulsion of claim 1 wherein the oil component additionally comprises a vegetable oil. 4. The oil-in-water emulsion of claim 3 wherein the vegetable oil is present in an amount of up to 10% by weight, based on the total weight of the oil component of the oil-in-water emulsion. 5. The oil-in-water emulsion of claim 3 wherein the vegetable oil is selected from the group consisting of soybean oil and safflower oil and mixtures thereof. 6. The oil-in-water emulsion of claim 1 comprising the oil component in an amount ranging from 5% to 30% by weight, based on the total weight of the emulsion. 7. The oil-in-water emulsion of claim 1 additionally comprising at least one phospholipid. 8. The oil-in-water emulsion of claim 7 wherein the phospholipid is a phosphatidyl choline. 9. The oil-in-water emulsion of claim 7 wherein the phospholipid is present in a weight ratio of phospholipid to triglycerides ranging from 0.05 to 0.07. 10. The oil-in-water emulsion of claim 1 additionally comprising an isotonic agent present in a concentration ranging from 20 to 25 g/L. 11. The oil-in-water emulsion of claim 1 comprising a pH adjusting agent. 12. The oil-in-water emulsion of claim 1 additionally comprising an antioxidant present in a concentration of up to 1 g/L. 13. The oil-in-water emulsion of claim 1 wherein the emulsion is parenterally applicable. 14. The oil-in-water emulsion of claim 1 wherein the mean droplet diameter of the oil droplets is below 250 nm at 20° C. 15. A pharmaceutical composition comprising an oil-in-water emulsion of claim 1. 16. An emulsion comprising: an oil component and a water component, the oil component comprising: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the oil component; wherein the fish oil triglycerides comprise omega-3 fatty acids, expressed as triglycerides, in an amount of at least 60%, based on the total weight of the fatty acids of the fish oil triglycerides;wherein the fish oil triglycerides comprise a total amount of EPA and DHA, expressed as triglycerides, of at least 45%, based on the total weight of the fatty acids of the fish oil triglycerides; and,at least one medium-chain triglyceride oil, wherein a total amount of the at least one medium-chain triglyceride oil is from about 10% to about 40% based on the weight of the oil component. 17. An oil composition suitable for use as an oil component of an oil-in-water emulsion, comprising: fish oil triglycerides in an amount of about 60% to about 90% based on the weight of the composition; wherein the fish oil triglycerides comprise omega-3 fatty acids, expressed as triglycerides, in an amount of at least 60%, based on the total weight of the fatty acids of the fish oil triglycerides;wherein the fish oil triglycerides comprise a total amount of EPA and DHA, expressed as triglycerides, of at least 45%, based on the total weight of the fatty acids of the fish oil triglycerides; and,at least one medium-chain triglyceride oil, wherein a total amount of the at least one medium-chain triglyceride oil is from about 10% to about 40% based on the weight of the composition. 18. The emulsion of claim 1, wherein the emulsion is an oil-in-water emulsion, and wherein the concentration of the oil component in the emulsion is 5 g/100 mL to less than 20 g/100 mL, or the concentration of the oil component in the emulsion is greater than 20 g/100 mL to 30 g/100 mL. 19. The emulsion of claim 16, wherein the emulsion is an oil-in-water emulsion, and wherein the concentration of the oil component in the emulsion is 5 g/100 mL to less than 20 g/100 mL, or the concentration of the oil component in the emulsion is greater than 20 g/100 mL to 30 g/100 mL. 20. The emulsion of claim 16, further comprising a vegetable oil. 21. The oil composition of claim 17, further comprising a vegetable oil. 22. A method of administering the emulsion of claim 1, comprising administering parenterally a dose of the emulsion to a human body. 23. A method for treating a human having a condition selected from the group consisting of a systemic inflammatory response syndrome, a respiratory distress syndrome, a nutritional and/or dietary cause of liver disease, an iatrogenic cause of liver disease, a pathological cause of liver disease, an immune modulation, head trauma, postoperative surgical stress, a myocardial infarction, cystic fibrosis and a combination thereof, said method comprising parenterally administering to said human an effective dosage amount of the emulsion according to claim 1. 24. A method of administering the emulsion of claim 16, comprising administering parenterally a dose of the emulsion to a human body. 25. A method of administering the oil composition of claim 17, comprising administering parenterally a dose of the oil composition to a human body.
Borisy, Alexis; Keith, Curtis; Foley, Michael A.; Stockwell, Brent R., Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders.
Kelley Vicki E. (Brookline MA) Bennett William M. (Portland OR), Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine.
Provost Pamela S. (Brighton MA) Driscoll David F. (West Bridgewater MA) Bistrian Bruce R. (Ipswich MA), Method of preparing total parenteral nutrition solutions.
Breivik Harald (Skjelsvik NOX) Brretzen Bernt (Porsgrunn NOX) Dahl Knut Helks (Ulefoss NOX) Krokan Hans Einar (Sjetnemarka NOX) Bnaa Kaare Harold (Troms NOX), Treatment and prevention of risk factors for cardiovascular diseases.
Grazia Sears IT; Janos Feher IT, Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiguinones and methods of using same.
Schlotzer, Ewald; Krampitz, Barbara; Suchner, Ulrich, Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.